PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40122F19028PK clinical site monitoring human — Goldbelt C6, LLC

Goldbelt C6, LLC holds $202.2M across 204 federal awards, concentrated at Department of State (DOS). This PIID sits alongside 5 related awards under parent HHSF223201710033I. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Sep 29, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs

Awarding office

Goldbelt C6, LLC

Recipient

Sep 29, 2025

PoP end

$847K

Obligated

$847K

Potential

541711

NAICS

R499

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number75F40122F19028

Also listed asHHSF223201710033I-75F40122F19028

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentGoldbelt C6, LLC

CAGE74AA1

UEILSY9B62DKAC8

NAICS541711

No full NAICS 541711 intel page yet. Browse NAICS intelligence

PSCR499

Parent IDIQ / IDVHHSF223201710033I

Place of performanceDAUPHIN ISLAND AL

Pricing typeLabor Hours

Extent competedNot Available For Competition

Related solicitationFDARFTOP1256410

PoP startJul 18, 2022

PoP end (current)Sep 29, 2025

Obligated$847K

Current value$847K

Potential value$847K

Clinical Site Monitoring in Human Subjects for an Extramural Study to Assess Dermal Pharmacokinetic (PK) and Systemic P… is a federal award for Fda Office Of Acq Grant Svcs held by Goldbelt C6, LLC. Estimated value $847K ($847K obligated). Current period of performance ends Sep 29, 2025. Last award drew 1 bidder. Place of performance: DAUPHIN ISLAND AL. Related solicitation FDARFTOP1256410.

Clinical site monitoring in human subjects for an extramural study to assess dermal pharmacokinetic (pk) and systemic pk under maximum exposure conditions of lidocaine/prilocaine cream to evaluate the dermal-systemic crosstalk at joanneum research, g. Latest action is a modification.

Recompete timing

Public

● Past PoP end (387 days ago)

Current PoP ended Sep 29, 2025 (387 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Want the durability read on 75F40122F19028? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Goldbelt C6, LLC — $202.2M obligated across 204 awards (firm-wide, all agencies) · lead buyer Department of State (DOS).

% of firm-wide obligated ($202.2M) · all agencies

Department of State (DOS)$78.2M · 39%Department of Health and Human Services (HHS)$55.5M · 27%Department of Defense (DOD)$55.2M · 27%Department of Homeland Security (DHS)$13.4M · 7%

Open full company profile →

Related awards

Same parent · incumbent

19AQMM24F0352

GBC6-065 TORP FOR INTER-AGENCY AND MULTILATERAL AFFAIRS OFFICER AND MEDIA PROGRAM ANALYST …

$1.0M

Feb 28, 2027

19AQMM24F0384

GBC6-063 TORP FOR SENIOR ADVISOR R/PPR EXPOS UNIT RENDERED TO R/PPR.

$675K

Feb 28, 2027

FA489022F0052

PRECISION MANAGEMENT EQUIPMENT LABORATORIES (PMEL) II SERVICES AT ROBINS AFB

$20.1M

Mar 31, 2027

70Z03826FS0000013

HAZMART SUPPORT SERVICES - OPTION PERIOD THREE

$2.1M

Mar 31, 2027

19AQMM22F1253

GOLDBELT C6, LLC PROFESSIONAL SUPPORT SERVICES - LEGISLATIVE MANAGEMENT OFFICER AND TWO (2…

$2.0M

Mar 31, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40122F19028?

75F40122F19028 (PK clinical site monitoring human) is a Fda Office Of Acq Grant Svcs award with a potential value of $847K, currently held by Goldbelt C6, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40122F19028?

Fda Office Of Acq Grant Svcs awarded 75F40122F19028 to Goldbelt C6, LLC (potential $847K).

Who is the incumbent on 75F40122F19028?

Goldbelt C6, LLC is the incumbent with $202.2M across 204 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2025.

When does Goldbelt C6, LLC’s 75F40122F19028 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40122F19028? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Jun 24, 2024